| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aims ; scope/editorial board
|
|
|
2005
|
18 |
3 |
p. iii-
1 p.
|
artikel
|
| 2 |
Anemia and the elderly: clinical considerations
|
Gabrilove, Janice
|
|
2005
|
18 |
3 |
p. 417-422
6 p.
|
artikel
|
| 3 |
Clinical characteristics of erythropoietin-associated pure red cell aplasia
|
Carson, Kenneth R.
|
|
2005
|
18 |
3 |
p. 467-472
6 p.
|
artikel
|
| 4 |
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review
|
Bohlius, Julia F.
|
|
2005
|
18 |
3 |
p. 449-454
6 p.
|
artikel
|
| 5 |
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group
|
Evens, Andrew M.
|
|
2005
|
18 |
3 |
p. 481-489
9 p.
|
artikel
|
| 6 |
Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines
|
Djulbegovic, Benjamin
|
|
2005
|
18 |
3 |
p. 455-466
12 p.
|
artikel
|
| 7 |
Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
|
D. Rizzo, J.
|
|
2005
|
18 |
3 |
p. 439-448
10 p.
|
artikel
|
| 8 |
Immunologic mechanisms of EPO-associated pure red cell aplasia
|
Schellekens, Huub
|
|
2005
|
18 |
3 |
p. 473-480
8 p.
|
artikel
|
| 9 |
Importance of biologic follow-ons: experience with EPO
|
Casadevall, Nicole
|
|
2005
|
18 |
3 |
p. 381-387
7 p.
|
artikel
|
| 10 |
Phase III clinical trials with darbepoetin: implications for clinicians
|
Glaspy, John
|
|
2005
|
18 |
3 |
p. 407-416
10 p.
|
artikel
|
| 11 |
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review
|
Desai, Jayesh
|
|
2005
|
18 |
3 |
p. 389-406
18 p.
|
artikel
|
| 12 |
Subject index for 18/3
|
|
|
2005
|
18 |
3 |
p. I-II
nvt p.
|
artikel
|
| 13 |
The ASH/ASCO clinical guidelines on the use of erythropoietin
|
Lichtin, Alan
|
|
2005
|
18 |
3 |
p. 433-438
6 p.
|
artikel
|
| 14 |
The blue cross blue shield assessment technology review: summary of findings
|
Bennett, Charles L.
|
|
2005
|
18 |
3 |
p. 423-431
9 p.
|
artikel
|
Tijdschrift beschrijving